Orion Oyj B (ORNBV.HE) — Quality & forensics
As of 2026-10-15 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 32
- Quality 83
- Growth 63
- Balance sheet 81
- Cash quality 28
- Capital allocation 47
- Momentum 83
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — above the −1.78 threshold the literature flags for earnings-manipulation risk. A screen, not an accusation.
Continue: the ORNBV.HE chart & overview
FAQ · from the current data · as of 2026-10-15
Quick answers
What is Orion Oyj B's Closelooknet quality reading?
The composite reads 62/100 across 7 modules, as of 2026-10-15: valuation 32, quality 83, growth 63, balance sheet 81, cash quality 28, capital allocation 47, momentum 83. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Orion Oyj B's Altman Z-Score?
12.90, which sits in the safe zone (above 2.99) as of 2026-10-15. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Orion Oyj B's Piotroski F-Score?
6 of 9, as of 2026-10-15. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Orion Oyj B's Beneish M-Score indicate?
-1.29 — above the −1.78 threshold the literature flags for earnings-manipulation risk, as of 2026-10-15. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- SAN.PA Sanofi SAindustry
- NVO Novo Nordisk A/Sindustry
- GSK GlaxoSmithKline PLC ADRindustry
- GRF.MC Grifols S.A.industry
- ABBV AbbVie Incindustry
- GILD Gilead Sciences Incindustry
- BIIB Biogen Incindustry
- PFE Pfizer Incindustry
- AMGN Amgen Incindustry
- MRK Merck & Company Incindustry
- OGN Organon & Coindustry
- JNJ Johnson & Johnsonindustry
- BMY Bristol-Myers Squibb Companyindustry
- SNY Sanofi ADRindustry
- AZN AstraZeneca PLCindustry
- HALO Halozyme Therapeutics Incsector
- DXCM DexCom Incsector
- ARGX.BR Argen-Xsector